Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/04/013220
CTRI/2018/04/013220
Recruiting
未知

A Clinical Study to Determine Association of Serum Vitamin D and Serum Prolactin with Uterine Fibroid in Indian Population

Asheesh Sachdeva0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Uterine Fibroid Female otherwise healthy

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Uterine Fibroid Female otherwise healthy
Sponsor
Asheesh Sachdeva
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Asheesh Sachdeva

Eligibility Criteria

Inclusion Criteria

  • •Inclusion Criteria for cases
  • •1\.Female subjects with 18 to 50 years of age (both inclusive) who are in perimenopausal status.
  • •2\.Documented evidence of atleast one uterine fibroid lesion of 2 cm3 or greater on ultrasonography.
  • •3\.Ability to provide consent.
  • •Inclusion Criteria for control
  • •1\.Female subjects with 18 to 50 years of age (both inclusive) who are in pre\-menopausal status.
  • •2\.Documented evidence of no uterine fibroid lesion on ultrasonography.
  • •3\.Ability to provide consent.

Exclusion Criteria

  • •1\.Pregnant and lactating women
  • •2\.Women with a history of abortion or miscarriage in last 6 months
  • •3\.Women with history of prior surgery for fibroids (myomectomy) or hysterectomy
  • •4\.Women with concomitant use of vitamin D supplements or history of vitamin D supplement within last 3 months
  • •5\.Women with concomitant use of hormonal treatment (including oral contraceptives) or history of hormonal treatment within last 3 months
  • •6\.Women with concomitant use of drug known to increase the serum prolactin levels \[e.g., haloperidol, chlorpromazine, thioridazine, thiothixene (typical antipsychotics); risperidone, amisulpride, molindone, zotepine (atypical antipsychotics); sertraline, fluoxetine, paroxetine, pargyline, clorgyline (antidepressants); buspirone, alprazolam (psychotropics); metoclopramide and domperidone (prokinetics), alpha\-methyldopa, reserpine and verapamil (antihypertensive), morphine (opiates)]
  • •7\.Women with diabetes mellitus, pituitary and hypothyroidism, chronic renal failure, or psychiatric disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical research for relationship between serum IL-31 and pruritus in patients who undergo hemodialysishemodialysis
JPRN-jRCT1080224513Chugai Pharmaceutical Co., Ltd.100
Recruiting
Not Applicable
Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndromePOEMS syndrome
JPRN-UMIN000044082Department of Neurology, Graduate School of Medicine, Chiba University100
Recruiting
Not Applicable
To investigate the correlation between serum bile acid level less than 40 micro mol/L in pregnancies affected with intrahepatic cholestasis of pregnancy(liver problem associated to pregnancy) and maternal and fetal outcomesHealth Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium
CTRI/2018/10/016128Max Smart Super Speciality Hospital
Completed
Not Applicable
Clinical analysis of the relations between serum zinc and testosterone in male patients with type 2 diabetes.Diabetes
JPRN-UMIN000016382wajima City Hospital40
Recruiting
Not Applicable
To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of themnon-squamous non-small cell lung cancer
JPRN-UMIN000012831agasaki Thoracic Oncology Group20